Danaher Stock Analysis & Ratings
1,939 Followers
DHR Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$233.47 - $332.88
Previous Close$297.27
Volume435.15K
Average Volume (3M)2.27M
Market CapN/A
Enterprise ValueN/A
P/E Ratio35.0
Beta0.88
Next EarningsOct 20, 2022
EPS Forecast$2.27
Last Dividend Ex-DateJun 23, 2022
Dividend Yield0.92 (0.31%)
1Y Price Target$324.36
Smart Score10
EPS (TTM)8.49
Shares Outstanding727,445,355
R-Squared0.39
Standard Deviation0.06
10 Day Avg. Volume2,654,937
30 Day Avg. Volume2,272,729
P/B Ratio-13.18
P/S Ratio6.61
P/CF Ratio24.50
P/FCF Ratio-54.10
Total Debt$20.06B
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/EbitdaN/A
Price Target Upside11.11% Upside
Rating ConsensusStrong Buy
Alpha0.01
Number of Analyst Covering11
Danaher News
P/E Ratio Range
The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.
---
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
DHR FAQ
What was Danaher’s price range in the past 12 months?
Danaher lowest stock price was $233.47 and its highest was $332.88 in the past 12 months.
What is Danaher’s market cap?
Currently, no data Available
What is Danaher’s price target?
The average price target for Danaher is $324.36. This is based on 11 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $350.00 ,the lowest forecast is $300.00. The average price target represents 11.11% Increase from the current price of $291.94.
The highest analyst price target is $350.00 ,the lowest forecast is $300.00. The average price target represents 11.11% Increase from the current price of $291.94.
What do analysts say about Danaher?
Danaher’s analyst rating consensus is a ‘Strong Buy. This is based on the ratings of 11 Wall Streets Analysts.
When is Danaher’s upcoming earnings report date?
Danaher’s upcoming earnings report date is Oct 20, 2022 which is in 62 days.
How were Danaher’s earnings last quarter?
Danaher released its earnings results on Jul 21, 2022. The company reported $2.76 earnings per share for the quarter, beating the consensus estimate of $2.349 by $0.411.
Is Danaher overvalued?
According to Wall Street analysts Danaher’s price is currently Undervalued.
Does Danaher pay dividends?
Danaher pays a Quarterly dividend of $0.25 which represents an annual dividend yield of 0.31%. Danaher’s last Quarterly dividend payment was on Jul 29, 2022. Danaher’s upcoming ex-dividend date is Jun 23, 2022
What is Danaher’s EPS estimate?
Danaher’s EPS estimate is $2.27.
How many shares outstanding does Danaher have?
Danaher has 727,445,400 shares outstanding.
What happened to Danaher’s price movement after its last earnings report?
Danaher reported an EPS of $2.76 in its last earnings report, beating expectations of $2.349. Following the earnings report the stock price went up 9.074%.
Which hedge fund is a major shareholder of Danaher?
Among the largest hedge funds holding Danaher’s share is Bishop Rock Capital, L.P.. It holds Danaher’s shares valued at 1B.
---
Danaher Stock Analysis
Smart ScoreOutperform
1
2
3
4
5
6
7
8
9
10
Analyst Forecast
Strong Buy
Average Price Target: $324.36
Blogger Sentiment
Bullish
DHR Sentiment 100% Sector Average 70%
Hedge Fund Holdings
▲ Increased
By 3.5M Shares Last Quarter.
Insider Transactions
▼ Sold Shares
Worth $3.0M over the Last 3 Months
Retail Investors
Very Positive
Last 7 Days ▲ 2.7% Last 30 Days ▲ 4.6%
News Sentiment
Neutral
Bullish 50% Bearish 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-7.07%
12-Months-Change
Fundamentals
Return on Equity
14.22%
Trailing 12-Months
Asset Growth
4.84%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Danaher Corp.
Founded in 1969 and headquartered in Washington, DC, Danaher Corp. engages in manufacturing, designing and marketing of professional, medical, industrial and commercial products and services. The company operates through three segments, including Life Sciences, Diagnostics, and Environmental & Applied Solutions.
---
---